Characterization of the 'White' Appearing Clots that Cause Acute Ischemic Stroke.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 30 06 2021
revised: 25 08 2021
accepted: 14 09 2021
pubmed: 1 10 2021
medline: 9 2 2022
entrez: 30 9 2021
Statut: ppublish

Résumé

Most clots retrieved from patients with acute ischemic stroke are 'red' in color. 'White' clots represent a less common entity and their histological composition is less known. Our aim was to investigate the composition, imaging and procedural characteristics of 'white' clots retrieved by mechanical thrombectomy. Seventy five 'white' thrombi were selected by visual inspection from a cohort of 760 clots collected as part of the RESTORE registry. Clots were evaluated histopathologically. Quantification of Martius Scarlett Blue stain identified platelets/other as the major component in 'white' clots' (mean of 55% of clot overall composition) followed by fibrin (31%), red blood cells (6%) and white blood cells (3%). 'White' clots contained significantly more platelets/other (p<0.001*) and collagen/calcification (p<0.001*) and less red blood cells (p<0.001*) and white blood cells (p=0.018*) than 'red' clots. The mean platelet and von Willebrand Factor expression was 43% and 24%, respectively. Adipocytes were found in four cases. 'White' clots were significantly smaller (p=0.016*), less hyperdense (p=0.005*) on computed tomography angiography/non-contrast CT and were associated with a smaller extracted clot area (p<0.001*) than 'red' clots. They primarily caused the occlusion of middle cerebral artery, were less likely to be removed by aspiration and more likely to require rescue-therapy for retrieval. 'White' clots represented 14% of our cohort and were platelet, von Willebrand Factor and collagen/calcification-rich. 'White' clots were smaller, less hyperdense, were associated with significantly more distal occlusions and were less successfully removed by aspiration alone than 'red' clots.

Identifiants

pubmed: 34592611
pii: S1052-3057(21)00532-2
doi: 10.1016/j.jstrokecerebrovasdis.2021.106127
pii:
doi:

Substances chimiques

von Willebrand Factor 0
Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106127

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Oana Madalina Mereuta (OM)

CÚRAM-SFI Research Centre for Medical Devices, National University of Ireland Galway, Galway, Ireland; Physiology Department, Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland. Electronic address: oanamadalina.mereuta@nuigalway.ie.

Rosanna Rossi (R)

CÚRAM-SFI Research Centre for Medical Devices, National University of Ireland Galway, Galway, Ireland; Physiology Department, Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland. Electronic address: rosanna.rossi@nuigalway.ie.

Andrew Douglas (A)

CÚRAM-SFI Research Centre for Medical Devices, National University of Ireland Galway, Galway, Ireland; Physiology Department, Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland. Electronic address: andrew.douglas@nuigalway.ie.

Sara Molina Gil (SM)

CÚRAM-SFI Research Centre for Medical Devices, National University of Ireland Galway, Galway, Ireland; Physiology Department, Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland. Electronic address: sara.molinagil@nuigalway.ie.

Seán Fitzgerald (S)

CÚRAM-SFI Research Centre for Medical Devices, National University of Ireland Galway, Galway, Ireland; Physiology Department, Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland. Electronic address: sean.fitzgerald@nuigalway.ie.

Abhay Pandit (A)

CÚRAM-SFI Research Centre for Medical Devices, National University of Ireland Galway, Galway, Ireland. Electronic address: abhay.pandit@nuigalway.ie.

Ray McCarthy (R)

Cerenovus, Galway Neuro Technology Centre, Galway, Ireland. Electronic address: rmccart9@its.jnj.com.

Michael Gilvarry (M)

Cerenovus, Galway Neuro Technology Centre, Galway, Ireland. Electronic address: mgilvarr@its.jnj.com.

Eric Ceder (E)

Department of Interventional and Diagnostic Neuroradiology, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. Electronic address: erik.ceder@vgregion.se.

Dennis Dunker (D)

Department of Interventional and Diagnostic Neuroradiology, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. Electronic address: dennis.dunker@vgregion.se.

Annika Nordanstig (A)

Department of Clinical Neurosciences, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg and Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: annika.nordanstig@vgregion.se.

Petra Redfors (P)

Department of Clinical Neurosciences, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg and Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: petra.redfors@gu.se.

Katarina Jood (K)

Department of Clinical Neurosciences, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg and Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: katarina.jood@neuro.gu.se.

Georgios Magoufis (G)

Metropolitan Hospital, Stroke Unit, Piraeus, Greece. Electronic address: magoufis@otenet.gr.

Klearchos Psychogios (K)

Metropolitan Hospital, Stroke Unit, Piraeus, Greece; Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.

Georgios Tsivgoulis (G)

Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.

Alan O'Hare (A)

Radiology Department, Beaumont Hospital and Royal College of Surgeons Ireland, Dublin, Ireland. Electronic address: alanohare@beaumont.ie.

Sarah Power (S)

Radiology Department, Beaumont Hospital and Royal College of Surgeons Ireland, Dublin, Ireland. Electronic address: sarahpower@beaumont.ie.

Paul Brennan (P)

Radiology Department, Beaumont Hospital and Royal College of Surgeons Ireland, Dublin, Ireland. Electronic address: paulbrennan@beaumont.ie.

András Nagy (A)

Department of Neurointerventions, National Institute of Neurosciences, Budapest, Hungary.

Ágnes Vadász (Á)

Department of Neurointerventions, National Institute of Neurosciences, Budapest, Hungary.

Waleed Brinjikji (W)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States. Electronic address: brinjikji.waleed@mayo.edu.

David F Kallmes (DF)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States. Electronic address: kallmes.david@mayo.edu.

Istvan Szikora (I)

Department of Neurointerventions, National Institute of Neurosciences, Budapest, Hungary. Electronic address: h13424szi@ella.hu.

Alexandros Rentzos (A)

Department of Interventional and Diagnostic Neuroradiology, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. Electronic address: alexandros.rentzos@vgregion.se.

Turgut Tatlisumak (T)

Department of Clinical Neurosciences, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg and Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: turgut.tatlisumak@neuro.gu.se.

John Thornton (J)

Radiology Department, Beaumont Hospital and Royal College of Surgeons Ireland, Dublin, Ireland. Electronic address: johnthornton@beaumont.ie.

Karen M Doyle (KM)

CÚRAM-SFI Research Centre for Medical Devices, National University of Ireland Galway, Galway, Ireland; Physiology Department, Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland. Electronic address: karen.doyle@nuigalway.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH